liver cirrhosis ascites R18 K74
Conditions
Interventions
Group 1: Non-interventional patient registry. Documentation of health outcome during routine medical Treatment.
Included will be all patients who are admitted to hospital with liver cirrhosis with s
Sponsors
Medizinische Hochschule Hannover
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: - Cirrhosis - Significant (point expiration) ascites on admission or during the hospitalization - Inpatient/ outpatient treatment at the Hannover Medical School
Exclusion criteria
Exclusion criteria: - Malignant tumor disease (excluding HCC within the Milan criteria) - Malignant cells in ascites - Complete Portal vein thrombosis - HIV infection - Congenital immunodeficiency - Condition after organ transplantation (except liver) - Condition after bone marrow transplantation
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Mortality within 28 days | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. mortality within 3 and 12 months 2. frequency of spontaneous bacterial peritonitis 3. Frequency of viral and bacterial infections 4. Spectrum of bacteria in ascites in patients with and without spontaneous bacterial peritonitis 5. Causes and incidence of acute-on-chronic liver failure 6. Change hepatic infections 7. Prevalence of drug interactions 8. Incidence and risk factors of renal failure 9. Influence of the intestinal microbiome | — |
Countries
Germany
Contacts
Public ContactJulia Kahlhöfer
Deutsche Leberstiftung
Outcome results
None listed